761 related articles for article (PubMed ID: 22980977)
1. Loss of 5-hydroxymethylcytosine is an epigenetic hallmark of melanoma.
Lian CG; Xu Y; Ceol C; Wu F; Larson A; Dresser K; Xu W; Tan L; Hu Y; Zhan Q; Lee CW; Hu D; Lian BQ; Kleffel S; Yang Y; Neiswender J; Khorasani AJ; Fang R; Lezcano C; Duncan LM; Scolyer RA; Thompson JF; Kakavand H; Houvras Y; Zon LI; Mihm MC; Kaiser UB; Schatton T; Woda BA; Murphy GF; Shi YG
Cell; 2012 Sep; 150(6):1135-46. PubMed ID: 22980977
[TBL] [Abstract][Full Text] [Related]
2. Ascorbate induces ten-eleven translocation (Tet) methylcytosine dioxygenase-mediated generation of 5-hydroxymethylcytosine.
Minor EA; Court BL; Young JI; Wang G
J Biol Chem; 2013 May; 288(19):13669-74. PubMed ID: 23548903
[TBL] [Abstract][Full Text] [Related]
3. Robust quantitative assessments of cytosine modifications and changes in the expressions of related enzymes in gastric cancer.
Du C; Kurabe N; Matsushima Y; Suzuki M; Kahyo T; Ohnishi I; Tanioka F; Tajima S; Goto M; Yamada H; Tao H; Shinmura K; Konno H; Sugimura H
Gastric Cancer; 2015 Jul; 18(3):516-25. PubMed ID: 25098926
[TBL] [Abstract][Full Text] [Related]
4. Modulation of ten-eleven translocation 1 (TET1), Isocitrate Dehydrogenase (IDH) expression, α-Ketoglutarate (α-KG), and DNA hydroxymethylation levels by interleukin-1β in primary human chondrocytes.
Haseeb A; Makki MS; Haqqi TM
J Biol Chem; 2014 Mar; 289(10):6877-6885. PubMed ID: 24469454
[TBL] [Abstract][Full Text] [Related]
5. TET2 repression by androgen hormone regulates global hydroxymethylation status and prostate cancer progression.
Takayama K; Misawa A; Suzuki T; Takagi K; Hayashizaki Y; Fujimura T; Homma Y; Takahashi S; Urano T; Inoue S
Nat Commun; 2015 Sep; 6():8219. PubMed ID: 26404510
[TBL] [Abstract][Full Text] [Related]
6. 5-hydroxymethylcytosine: a new insight into epigenetics in cancer.
Ye C; Li L
Cancer Biol Ther; 2014 Jan; 15(1):10-5. PubMed ID: 24253310
[TBL] [Abstract][Full Text] [Related]
7. Epigenetic silencing of TET2 and TET3 induces an EMT-like process in melanoma.
Gong F; Guo Y; Niu Y; Jin J; Zhang X; Shi X; Zhang L; Li R; Chen L; Ma RZ
Oncotarget; 2017 Jan; 8(1):315-328. PubMed ID: 27852070
[TBL] [Abstract][Full Text] [Related]
8. 5-hydroxymethylcytosine in cancer: significance in diagnosis and therapy.
Vasanthakumar A; Godley LA
Cancer Genet; 2015 May; 208(5):167-77. PubMed ID: 25892122
[TBL] [Abstract][Full Text] [Related]
9. Characterization of TET and IDH gene expression in chronic lymphocytic leukemia: comparison with normal B cells and prognostic significance.
Van Damme M; Crompot E; Meuleman N; Maerevoet M; Mineur P; Bron D; Lagneaux L; Stamatopoulos B
Clin Epigenetics; 2016; 8():132. PubMed ID: 27980696
[TBL] [Abstract][Full Text] [Related]
10. Decrease of 5-hydroxymethylcytosine is associated with progression of hepatocellular carcinoma through downregulation of TET1.
Liu C; Liu L; Chen X; Shen J; Shan J; Xu Y; Yang Z; Wu L; Xia F; Bie P; Cui Y; Bian XW; Qian C
PLoS One; 2013; 8(5):e62828. PubMed ID: 23671639
[TBL] [Abstract][Full Text] [Related]
11. TET family proteins and 5-hydroxymethylcytosine in esophageal squamous cell carcinoma.
Murata A; Baba Y; Ishimoto T; Miyake K; Kosumi K; Harada K; Kurashige J; Iwagami S; Sakamoto Y; Miyamoto Y; Yoshida N; Yamamoto M; Oda S; Watanabe M; Nakao M; Baba H
Oncotarget; 2015 Sep; 6(27):23372-82. PubMed ID: 26093090
[TBL] [Abstract][Full Text] [Related]
12. Reduction of global 5-hydroxymethylcytosine is a poor prognostic factor in breast cancer patients, especially for an ER/PR-negative subtype.
Tsai KW; Li GC; Chen CH; Yeh MH; Huang JS; Tseng HH; Fu TY; Liou HH; Pan HW; Huang SF; Chen CC; Chang HY; Ger LP; Chang HT
Breast Cancer Res Treat; 2015 Aug; 153(1):219-34. PubMed ID: 26253945
[TBL] [Abstract][Full Text] [Related]
13. TET2-mediated 5-hydroxymethylcytosine induces genetic instability and mutagenesis.
Mahfoudhi E; Talhaoui I; Cabagnols X; Della Valle V; Secardin L; Rameau P; Bernard OA; Ishchenko AA; Abbes S; Vainchenker W; Saparbaev M; Plo I
DNA Repair (Amst); 2016 Jul; 43():78-88. PubMed ID: 27289557
[TBL] [Abstract][Full Text] [Related]
14. Genome-wide characterization of 5-hydoxymethylcytosine in melanoma reveals major differences with nevus.
Salgado C; Oosting J; Janssen B; Kumar R; Gruis N; van Doorn R
Genes Chromosomes Cancer; 2020 Jun; 59(6):366-374. PubMed ID: 32017278
[TBL] [Abstract][Full Text] [Related]
15. Epigenetic Modifications in the Biology of Nonalcoholic Fatty Liver Disease: The Role of DNA Hydroxymethylation and TET Proteins.
Pirola CJ; Scian R; Gianotti TF; Dopazo H; Rohr C; Martino JS; Castaño GO; Sookoian S
Medicine (Baltimore); 2015 Sep; 94(36):e1480. PubMed ID: 26356709
[TBL] [Abstract][Full Text] [Related]
16. 5-Hydroxymethylcytosine: An epigenetic mark frequently deregulated in cancer.
Kroeze LI; van der Reijden BA; Jansen JH
Biochim Biophys Acta; 2015 Apr; 1855(2):144-54. PubMed ID: 25579174
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of TET Family Gene Expression and 5-Hydroxymethylcytosine as Potential Epigenetic Markers in Non-small Cell Lung Cancer.
Alrehaili AA; Gharib AF; Alghamdi SA; Alhazmi A; Al-Shehri SS; Hagag HM; Alsaeedi FA; Alhuthali HM; Raafat N; Etewa RL; Elsawy WH
In Vivo; 2023; 37(1):445-453. PubMed ID: 36593050
[TBL] [Abstract][Full Text] [Related]
18. Differential expression of ten-eleven translocation genes in endometrial cancers.
Ciesielski P; Jóźwiak P; Wójcik-Krowiranda K; Forma E; Cwonda Ł; Szczepaniec S; Bieńkiewicz A; Bryś M; Krześlak A
Tumour Biol; 2017 Mar; 39(3):1010428317695017. PubMed ID: 28349832
[TBL] [Abstract][Full Text] [Related]
19. Neocortical Tet3-mediated accumulation of 5-hydroxymethylcytosine promotes rapid behavioral adaptation.
Li X; Wei W; Zhao QY; Widagdo J; Baker-Andresen D; Flavell CR; D'Alessio A; Zhang Y; Bredy TW
Proc Natl Acad Sci U S A; 2014 May; 111(19):7120-5. PubMed ID: 24757058
[TBL] [Abstract][Full Text] [Related]
20. TET2-mediated Cdkn2A DNA hydroxymethylation in midbrain dopaminergic neuron injury of Parkinson's disease.
Wu TT; Liu T; Li X; Chen YJ; Chen TJ; Zhu XY; Chen JL; Li Q; Liu Y; Feng Y; Wu YC
Hum Mol Genet; 2020 May; 29(8):1239-1252. PubMed ID: 32037456
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]